Ann Hunter

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

Alan K. Burnett, Robert K. Hills, Donald Milligan et al. · Journal of Clinical Oncology · 2010 · 644 citations · Full text

Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells

Cristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton et al. · Journal of Clinical Investigation · 2009 · 556 citations · Full text

Mixed-phenotype Acute Leukemia, Apoptosis, Immunology +21

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · The Lancet Oncology · 2015 · 533 citations

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +8

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]

Norbert Schmitz, Peter Dreger, Meinolf Suttorp et al. · Blood · 1995 · 487 citations · Full text

Sequencing of N-Linked Oligosaccharides Directly from Protein Gels: In-Gel Deglycosylation Followed by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Normal-Phase High-Performance Liquid Chromatography

Bernhard Küster, Susan F. Wheeler, Ann Hunter et al. · Analytical Biochemistry · 1997 · 357 citations

Engineering, Glycosylation, Biochemistry +14